About Wynclark Pharmaceuticals Private Limited
Data last updated:
Wynclark Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Medplus Health Services Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 February 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2007PTC052676. Its GSTIN is 36AAECM9413G2ZF (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹14.08 Cr and a paid-up capital of ₹14.08 Cr. It was formerly known as Medplus Mart Global Private Limited and Medplus Smart Private Limited. It is led by directors including Satya Murali Krishna Kammila (Whole-Time Director) and Paidiwar Srinivas.
Its last annual general meeting (AGM) was held on 05 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground Floor 12 – 7 – 20/64/2 Survey No. 793 Goods Shed Road Moosapet Kukatpally, Hyderabad, Telangana, India – 500018.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.13 Cr, a decline of 70% compared to the previous year. For the same year it recorded a net profit of ₹86.9 Lakh (net margin 6.6%) and EBITDA of ₹1.22 Cr (EBITDA margin 9.3%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 76% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 1 case is pending. The company has 2 deals on record (2 secondary share transfers); the latest was in September 2013. Its 5 peer companies in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 3 smaller; the largest is Iaso Pharmaceuticals Private Limited with revenue of ₹13.2 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medplusindia.com.
Company details
Name history
Wynclark Pharmaceuticals has undergone 4 name changes throughout its history. The current legal name is Wynclark Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Wynclark Pharmaceuticals Private Limited | Current |
| Medplus Mart Global Private Limited | Previous |
| Medplus Smart Private Limited | Previous |
| Medplus Pathlabs Private Limited | Previous |
| Medsupply Distributors Private Limited | Previous |
CIN history
Wynclark Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2007PTC052676. The current CIN is U24239TG2007PTC052676, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2007PTC052676 | Current |
| U24239AP2007PTC052676 | Previous |
Contact details
Wynclark Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is medplusindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Apps
- Registered AddressGround Floor 12 – 7 – 20/64/2 Survey No. 793 Goods Shed Road Moosapet Kukatpally, Hyderabad, Telangana, India – 500018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Wynclark Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Wynclark Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Wynclark Pharmaceuticals Private Limited, buy the company report.
Financials of Wynclark Pharmaceuticals Private Limited
FY 2025 filings availableWynclark Pharmaceuticals Private Limited reported revenue of ₹13.13 Cr (down 70% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 70% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 76%. EBITDA fell 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.22 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹86.9 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.3% | ||||
| Net Profit Margin | 6.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wynclark Pharmaceuticals Private Limited, buy the company report.
Board of directors and KMP of Wynclark Pharmaceuticals Private Limited
Wynclark Pharmaceuticals Private Limited currently reports 3 directors and 1 key managerial person. 7 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sujit Kumar Mahato Also directs: Optival Health Solutions Private Limited | Cfo | 16 Nov 2022 | 3 Years 11 Months | Current |
| Paidiwar Srinivas Also directs: Dureleg Manufacturing Private Limited, Sai Sridhar Pharma Private Limited, Deccan Medisales Private Limited and 5 more | Director | 03 Aug 2013 | 13 Years 2 Months | Current |
| Bhaskar Reddy Cherukupalli Also directs: Clearancekart Private Limited, Kalyani Meditimes Private Limited, Agilepro (India) Ventures LLP and 5 more | Director | 29 Sep 2021 | 5 Years 1 Months | Current |
| Satya Murali Krishna Kammila Also directs: Dureleg Manufacturing Private Limited, Sai Sridhar Pharma Private Limited, Deccan Medisales Private Limited and 5 more | Whole-Time Director | 29 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Wynclark Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Iaso Pharmaceuticals Private Limited | ₹13.2 Cr (FY 2025) | 4.0% | New Delhi, Delhi, India | |||
| Bio Warriors Pharmaceucticals Private Limited | ₹13.16 Cr (FY 2024) | 15.0% | Bangalore, Karnataka, India | |||
| Wynclark Pharmaceuticals Private Limitedthis company | ₹13.13 Cr (FY 2025) | ₹86.9 Lakh | 6.6% | -70.0% | 7 | Hyderabad, Telangana, India |
| Modi Remedies Private Limited | ₹13.12 Cr (FY 2025) | 35.0% | Cuttack, Odisha, India | |||
| Knoll Pharmaceuticals Limited | ₹13.12 Cr (FY 2025) | 124.0% | Badli, Delhi, India | |||
| M B and K Pharma Private Limited | ₹13.11 Cr (FY 2025) | 3.0% | Varanasi, Uttar Pradesh, India |
To see the full peer comparison of Wynclark Pharmaceuticals Private Limited, buy the company report.
Auditor
Wynclark Pharmaceuticals Private Limited is audited by Gphk & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Gphk & Associates | FY 2023 | 008053S |
Shareholding
The shareholding of Wynclark Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Wynclark Pharmaceuticals Private Limited, buy the company report.
Deals & funding
Wynclark Pharmaceuticals Private Limited has 2 deals on record (2 secondary share transfers); the latest was in September 2013.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2007 | Secondary share transfer | Undisclosed | Buyer: Medplus Health Services Limited , an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Wynclark Pharmaceuticals Private Limited has 3 court cases on record: 1 filed by Wynclark Pharmaceuticals, 2 filed against it. 1 case is pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 1 | 1 |
| District courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Sun Pharma Laboratories Limited | Pending |
| High Court | Interim or miscellaneous application | Filed by the company against Pure and Cure Healthcare Pvt. Ltd | Disposed |
| District court, Guntur, Andhra Pradesh | Court case (ID) | Filed against the company by an individual | Disposed |
To see the full case history of Wynclark Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wynclark Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Wynclark Pharmaceuticals Private Limited has a workforce of 7 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
GST
Wynclark Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECM9413G2ZF | Telangana | Active | 16 Nov 2019 |
To see the full GST registrations and return filing status of Wynclark Pharmaceuticals Private Limited, buy the company report.
Recent activity
Wynclark Pharmaceuticals Private Limited has 11 board changes on record since 2009: 4 appointments and 7 cessations. The latest: Sujit Kumar Mahato was appointed as CFO on 16 Nov 2022.
2 earlier events are in the company report.
Frequently asked questions
Wynclark Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 February 2007 (19+ years old) and is registered under CIN U24239TG2007PTC052676.
Wynclark Pharmaceuticals has 4 current directors and KMP:
- Satya Murali Krishna Kammila - Whole-Time Director
- Paidiwar Srinivas - Director
- Bhaskar Reddy Cherukupalli - Director
- Sujit Kumar Mahato - Cfo
The latest financial statements of Wynclark Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 05 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Wynclark Pharmaceuticals is 36AAECM9413G2ZF, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Wynclark Pharmaceuticals is U24239TG2007PTC052676. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wynclark Pharmaceuticals has 3 court cases on record: 1 filed by the company and 2 filed against it. 1 is pending. Most are in the high courts.
Wynclark Pharmaceuticals was incorporated on 08 February 2007, making it 19+ years old. It is registered with the Registrar of Companies, Hyderabad.
Wynclark Pharmaceuticals has 2 deals on record (2 secondary share transfers); the latest was in September 2013.
The peers of Wynclark Pharmaceuticals by revenue are Iaso Pharmaceuticals Private Limited, Bio Warriors Pharmaceucticals Private Limited, Modi Remedies Private Limited, Knoll Pharmaceuticals Limited, M B and K Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Sujit Kumar Mahato was appointed as CFO on 16 Nov 2022. Hemanth Kundavaram ceased to be CFO on 05 Jun 2022. Parag Jain ceased to be Company Secretary on 14 Jan 2022. Wynclark Pharmaceuticals has 11 board changes on record in total.
Wynclark Pharmaceuticals can be reached through the website medplusindia.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
